December 17, 2018

Athersys Extends Agreement with Healios, Receives $2 Million

Athersys, a Cleveland regenerative medicine company, is expanding its MultiStem cell therapy treatment collaboration with Healios, its Japanese partner. As part of the expansion, Healios will make a $2 million payment for the development and commercialization of MultiStem therapy for certain indications in China.